Anti-aging Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Description

List of Tables

The global market for Anti-aging Drugs was estimated to be worth US$ 11030 million in 2024 and is forecast to a readjusted size of US$ 23970 million by 2031 with a CAGR of 11.9% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Anti-aging Drugs cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Botox and filler treatments are into the drift. Botox encompasses purified bacteria that freezes muscles. In doing so, Botox can help minimalize the appearance of wrinkles and lines caused by facial fillers and expressions contain elements that add plumpness to areas that have thinned due to aging.

The anti-aging drugs market is propelled by several compelling factors. Most notably, the global population is aging rapidly-by 2050, the number of people aged 65 and above is projected to reach around 1.5-2.1 billion. This demographic shift fuels demand for therapies targeting age-related diseases like cardiovascular disorders, diabetes, neurodegenerative conditions, osteoporosis, and skin photoaging . Meanwhile, breakthroughs in biotechnology-spanning CRISPR, senolytics, mTOR inhibitors, NAD+ boosters, regenerative medicine, gene-editing, and AI-enabled drug discovery-are unlocking new therapeutic avenues. Rising disposable incomes, especially in emerging markets, and heightened consumer demand for wellness and aesthetic solutions further support market expansion.

Nevertheless, the sector faces significant hurdles. Chief among them are the exorbitant research and R&D costs-developing these drugs typically involves multi-year investment, expensive clinical trials, and complex regulatory approval procedures, often costing upwards of $1 billion . Regulatory ambiguity is another barrier: aging is not formally recognized as a disease, and oversight for aging-related therapies remains unclear, delaying approvals . Limited clinical evidence, short-term trial data, and safety concerns (e.g., off-label use, side effects, lack of biomarkers) hinder adoption

This report aims to provide a comprehensive presentation of the global market for Anti-aging Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Anti-aging Drugs by region & country, by Type, and by Application.

The Anti-aging Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-aging Drugs.

Market Segmentation

By Company

AbbVie
Galderma
LG Life Sciences
Merz
Medytox
Hugel
Croma-Pharma
Beijing IMEIK
Bloomage Bio
Elravie (Humedix)
Cleviel (Pharma Research Products)
Haohai Biological
Teoxane
Sinclair
Suneva Medical
CG Bio
SciVision Biotech
Prollenium
Bohus BioTech
Caregen
Ipsen
LIBP
US World Meds
Daewoong
JETEMA

Segment by Type

Dermal Fillers
Botulinum Toxin
Others

Segment by Application

Hospital
Beauty Parlor
Others

By Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Anti-aging Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Anti-aging Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Anti-aging Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

1 Market Overview

1.1 Anti-aging Drugs Product Introduction
1.2 Global Anti-aging Drugs Market Size Forecast
- 1.2.1 Global Anti-aging Drugs Sales Value (2020-2031)
- 1.2.2 Global Anti-aging Drugs Sales Volume (2020-2031)
- 1.2.3 Global Anti-aging Drugs Sales Price (2020-2031)
1.3 Anti-aging Drugs Market Trends & Drivers
- 1.3.1 Anti-aging Drugs Industry Trends
- 1.3.2 Anti-aging Drugs Market Drivers & Opportunity
- 1.3.3 Anti-aging Drugs Market Challenges
- 1.3.4 Anti-aging Drugs Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Anti-aging Drugs Players Revenue Ranking (2024)
2.2 Global Anti-aging Drugs Revenue by Company (2020-2025)
2.3 Global Anti-aging Drugs Players Sales Volume Ranking (2024)
2.4 Global Anti-aging Drugs Sales Volume by Company Players (2020-2025)
2.5 Global Anti-aging Drugs Average Price by Company (2020-2025)
2.6 Key Manufacturers Anti-aging Drugs Manufacturing Base and Headquarters
2.7 Key Manufacturers Anti-aging Drugs Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Anti-aging Drugs
2.9 Anti-aging Drugs Market Competitive Analysis
- 2.9.1 Anti-aging Drugs Market Concentration Rate (2020-2025)
- 2.9.2 Global 5 and 10 Largest Manufacturers by Anti-aging Drugs Revenue in 2024
- 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-aging Drugs as of 2024)
2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type
- 3.1.1 Dermal Fillers
- 3.1.2 Botulinum Toxin
- 3.1.3 Others
3.2 Global Anti-aging Drugs Sales Value by Type
- 3.2.1 Global Anti-aging Drugs Sales Value by Type (2020 VS 2024 VS 2031)
- 3.2.2 Global Anti-aging Drugs Sales Value, by Type (2020-2031)
- 3.2.3 Global Anti-aging Drugs Sales Value, by Type (%) (2020-2031)
3.3 Global Anti-aging Drugs Sales Volume by Type
- 3.3.1 Global Anti-aging Drugs Sales Volume by Type (2020 VS 2024 VS 2031)
- 3.3.2 Global Anti-aging Drugs Sales Volume, by Type (2020-2031)
- 3.3.3 Global Anti-aging Drugs Sales Volume, by Type (%) (2020-2031)
3.4 Global Anti-aging Drugs Average Price by Type (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application
- 4.1.1 Hospital
- 4.1.2 Beauty Parlor
- 4.1.3 Others
4.2 Global Anti-aging Drugs Sales Value by Application
- 4.2.1 Global Anti-aging Drugs Sales Value by Application (2020 VS 2024 VS 2031)
- 4.2.2 Global Anti-aging Drugs Sales Value, by Application (2020-2031)
- 4.2.3 Global Anti-aging Drugs Sales Value, by Application (%) (2020-2031)
4.3 Global Anti-aging Drugs Sales Volume by Application
- 4.3.1 Global Anti-aging Drugs Sales Volume by Application (2020 VS 2024 VS 2031)
- 4.3.2 Global Anti-aging Drugs Sales Volume, by Application (2020-2031)
- 4.3.3 Global Anti-aging Drugs Sales Volume, by Application (%) (2020-2031)
4.4 Global Anti-aging Drugs Average Price by Application (2020-2031)

5 Segmentation by Region

5.1 Global Anti-aging Drugs Sales Value by Region
- 5.1.1 Global Anti-aging Drugs Sales Value by Region: 2020 VS 2024 VS 2031
- 5.1.2 Global Anti-aging Drugs Sales Value by Region (2020-2025)
- 5.1.3 Global Anti-aging Drugs Sales Value by Region (2026-2031)
- 5.1.4 Global Anti-aging Drugs Sales Value by Region (%), (2020-2031)
5.2 Global Anti-aging Drugs Sales Volume by Region
- 5.2.1 Global Anti-aging Drugs Sales Volume by Region: 2020 VS 2024 VS 2031
- 5.2.2 Global Anti-aging Drugs Sales Volume by Region (2020-2025)
- 5.2.3 Global Anti-aging Drugs Sales Volume by Region (2026-2031)
- 5.2.4 Global Anti-aging Drugs Sales Volume by Region (%), (2020-2031)
5.3 Global Anti-aging Drugs Average Price by Region (2020-2031)
5.4 North America
- 5.4.1 North America Anti-aging Drugs Sales Value, 2020-2031
- 5.4.2 North America Anti-aging Drugs Sales Value by Country (%), 2024 VS 2031
5.5 Europe
- 5.5.1 Europe Anti-aging Drugs Sales Value, 2020-2031
- 5.5.2 Europe Anti-aging Drugs Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
- 5.6.1 Asia Pacific Anti-aging Drugs Sales Value, 2020-2031
- 5.6.2 Asia Pacific Anti-aging Drugs Sales Value by Region (%), 2024 VS 2031
5.7 South America
- 5.7.1 South America Anti-aging Drugs Sales Value, 2020-2031
- 5.7.2 South America Anti-aging Drugs Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
- 5.8.1 Middle East & Africa Anti-aging Drugs Sales Value, 2020-2031
- 5.8.2 Middle East & Africa Anti-aging Drugs Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Anti-aging Drugs Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Anti-aging Drugs Sales Value and Sales Volume
- 6.2.1 Key Countries/Regions Anti-aging Drugs Sales Value, 2020-2031
- 6.2.2 Key Countries/Regions Anti-aging Drugs Sales Volume, 2020-2031
6.3 United States
- 6.3.1 United States Anti-aging Drugs Sales Value, 2020-2031
- 6.3.2 United States Anti-aging Drugs Sales Value by Type (%), 2024 VS 2031
- 6.3.3 United States Anti-aging Drugs Sales Value by Application, 2024 VS 2031
6.4 Europe
- 6.4.1 Europe Anti-aging Drugs Sales Value, 2020-2031
- 6.4.2 Europe Anti-aging Drugs Sales Value by Type (%), 2024 VS 2031
- 6.4.3 Europe Anti-aging Drugs Sales Value by Application, 2024 VS 2031
6.5 China
- 6.5.1 China Anti-aging Drugs Sales Value, 2020-2031
- 6.5.2 China Anti-aging Drugs Sales Value by Type (%), 2024 VS 2031
- 6.5.3 China Anti-aging Drugs Sales Value by Application, 2024 VS 2031
6.6 Japan
- 6.6.1 Japan Anti-aging Drugs Sales Value, 2020-2031
- 6.6.2 Japan Anti-aging Drugs Sales Value by Type (%), 2024 VS 2031
- 6.6.3 Japan Anti-aging Drugs Sales Value by Application, 2024 VS 2031
6.7 South Korea
- 6.7.1 South Korea Anti-aging Drugs Sales Value, 2020-2031
- 6.7.2 South Korea Anti-aging Drugs Sales Value by Type (%), 2024 VS 2031
- 6.7.3 South Korea Anti-aging Drugs Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
- 6.8.1 Southeast Asia Anti-aging Drugs Sales Value, 2020-2031
- 6.8.2 Southeast Asia Anti-aging Drugs Sales Value by Type (%), 2024 VS 2031
- 6.8.3 Southeast Asia Anti-aging Drugs Sales Value by Application, 2024 VS 2031
6.9 India
- 6.9.1 India Anti-aging Drugs Sales Value, 2020-2031
- 6.9.2 India Anti-aging Drugs Sales Value by Type (%), 2024 VS 2031
- 6.9.3 India Anti-aging Drugs Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 AbbVie
- 7.1.1 AbbVie Company Information
- 7.1.2 AbbVie Introduction and Business Overview
- 7.1.3 AbbVie Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.1.4 AbbVie Anti-aging Drugs Product Offerings
- 7.1.5 AbbVie Recent Development
7.2 Galderma
- 7.2.1 Galderma Company Information
- 7.2.2 Galderma Introduction and Business Overview
- 7.2.3 Galderma Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.2.4 Galderma Anti-aging Drugs Product Offerings
- 7.2.5 Galderma Recent Development
7.3 LG Life Sciences
- 7.3.1 LG Life Sciences Company Information
- 7.3.2 LG Life Sciences Introduction and Business Overview
- 7.3.3 LG Life Sciences Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.3.4 LG Life Sciences Anti-aging Drugs Product Offerings
- 7.3.5 LG Life Sciences Recent Development
7.4 Merz
- 7.4.1 Merz Company Information
- 7.4.2 Merz Introduction and Business Overview
- 7.4.3 Merz Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.4.4 Merz Anti-aging Drugs Product Offerings
- 7.4.5 Merz Recent Development
7.5 Medytox
- 7.5.1 Medytox Company Information
- 7.5.2 Medytox Introduction and Business Overview
- 7.5.3 Medytox Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.5.4 Medytox Anti-aging Drugs Product Offerings
- 7.5.5 Medytox Recent Development
7.6 Hugel
- 7.6.1 Hugel Company Information
- 7.6.2 Hugel Introduction and Business Overview
- 7.6.3 Hugel Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.6.4 Hugel Anti-aging Drugs Product Offerings
- 7.6.5 Hugel Recent Development
7.7 Croma-Pharma
- 7.7.1 Croma-Pharma Company Information
- 7.7.2 Croma-Pharma Introduction and Business Overview
- 7.7.3 Croma-Pharma Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.7.4 Croma-Pharma Anti-aging Drugs Product Offerings
- 7.7.5 Croma-Pharma Recent Development
7.8 Beijing IMEIK
- 7.8.1 Beijing IMEIK Company Information
- 7.8.2 Beijing IMEIK Introduction and Business Overview
- 7.8.3 Beijing IMEIK Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.8.4 Beijing IMEIK Anti-aging Drugs Product Offerings
- 7.8.5 Beijing IMEIK Recent Development
7.9 Bloomage Bio
- 7.9.1 Bloomage Bio Company Information
- 7.9.2 Bloomage Bio Introduction and Business Overview
- 7.9.3 Bloomage Bio Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.9.4 Bloomage Bio Anti-aging Drugs Product Offerings
- 7.9.5 Bloomage Bio Recent Development
7.10 Elravie (Humedix)
- 7.10.1 Elravie (Humedix) Company Information
- 7.10.2 Elravie (Humedix) Introduction and Business Overview
- 7.10.3 Elravie (Humedix) Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.10.4 Elravie (Humedix) Anti-aging Drugs Product Offerings
- 7.10.5 Elravie (Humedix) Recent Development
7.11 Cleviel (Pharma Research Products)
- 7.11.1 Cleviel (Pharma Research Products) Company Information
- 7.11.2 Cleviel (Pharma Research Products) Introduction and Business Overview
- 7.11.3 Cleviel (Pharma Research Products) Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.11.4 Cleviel (Pharma Research Products) Anti-aging Drugs Product Offerings
- 7.11.5 Cleviel (Pharma Research Products) Recent Development
7.12 Haohai Biological
- 7.12.1 Haohai Biological Company Information
- 7.12.2 Haohai Biological Introduction and Business Overview
- 7.12.3 Haohai Biological Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.12.4 Haohai Biological Anti-aging Drugs Product Offerings
- 7.12.5 Haohai Biological Recent Development
7.13 Teoxane
- 7.13.1 Teoxane Company Information
- 7.13.2 Teoxane Introduction and Business Overview
- 7.13.3 Teoxane Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.13.4 Teoxane Anti-aging Drugs Product Offerings
- 7.13.5 Teoxane Recent Development
7.14 Sinclair
- 7.14.1 Sinclair Company Information
- 7.14.2 Sinclair Introduction and Business Overview
- 7.14.3 Sinclair Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.14.4 Sinclair Anti-aging Drugs Product Offerings
- 7.14.5 Sinclair Recent Development
7.15 Suneva Medical
- 7.15.1 Suneva Medical Company Information
- 7.15.2 Suneva Medical Introduction and Business Overview
- 7.15.3 Suneva Medical Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.15.4 Suneva Medical Anti-aging Drugs Product Offerings
- 7.15.5 Suneva Medical Recent Development
7.16 CG Bio
- 7.16.1 CG Bio Company Information
- 7.16.2 CG Bio Introduction and Business Overview
- 7.16.3 CG Bio Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.16.4 CG Bio Anti-aging Drugs Product Offerings
- 7.16.5 CG Bio Recent Development
7.17 SciVision Biotech
- 7.17.1 SciVision Biotech Company Information
- 7.17.2 SciVision Biotech Introduction and Business Overview
- 7.17.3 SciVision Biotech Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.17.4 SciVision Biotech Anti-aging Drugs Product Offerings
- 7.17.5 SciVision Biotech Recent Development
7.18 Prollenium
- 7.18.1 Prollenium Company Information
- 7.18.2 Prollenium Introduction and Business Overview
- 7.18.3 Prollenium Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.18.4 Prollenium Anti-aging Drugs Product Offerings
- 7.18.5 Prollenium Recent Development
7.19 Bohus BioTech
- 7.19.1 Bohus BioTech Company Information
- 7.19.2 Bohus BioTech Introduction and Business Overview
- 7.19.3 Bohus BioTech Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.19.4 Bohus BioTech Anti-aging Drugs Product Offerings
- 7.19.5 Bohus BioTech Recent Development
7.20 Caregen
- 7.20.1 Caregen Company Information
- 7.20.2 Caregen Introduction and Business Overview
- 7.20.3 Caregen Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.20.4 Caregen Anti-aging Drugs Product Offerings
- 7.20.5 Caregen Recent Development
7.21 Ipsen
- 7.21.1 Ipsen Company Information
- 7.21.2 Ipsen Introduction and Business Overview
- 7.21.3 Ipsen Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.21.4 Ipsen Anti-aging Drugs Product Offerings
- 7.21.5 Ipsen Recent Development
7.22 LIBP
- 7.22.1 LIBP Company Information
- 7.22.2 LIBP Introduction and Business Overview
- 7.22.3 LIBP Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.22.4 LIBP Anti-aging Drugs Product Offerings
- 7.22.5 LIBP Recent Development
7.23 US World Meds
- 7.23.1 US World Meds Company Information
- 7.23.2 US World Meds Introduction and Business Overview
- 7.23.3 US World Meds Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.23.4 US World Meds Anti-aging Drugs Product Offerings
- 7.23.5 US World Meds Recent Development
7.24 Daewoong
- 7.24.1 Daewoong Company Information
- 7.24.2 Daewoong Introduction and Business Overview
- 7.24.3 Daewoong Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.24.4 Daewoong Anti-aging Drugs Product Offerings
- 7.24.5 Daewoong Recent Development
7.25 JETEMA
- 7.25.1 JETEMA Company Information
- 7.25.2 JETEMA Introduction and Business Overview
- 7.25.3 JETEMA Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.25.4 JETEMA Anti-aging Drugs Product Offerings
- 7.25.5 JETEMA Recent Development

8 Industry Chain Analysis

8.1 Anti-aging Drugs Industrial Chain
8.2 Anti-aging Drugs Upstream Analysis
- 8.2.1 Key Raw Materials
- 8.2.2 Raw Materials Key Suppliers
- 8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
- 8.5.1 Anti-aging Drugs Sales Model
- 8.5.2 Sales Channel
- 8.5.3 Anti-aging Drugs Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology
- 10.1.1 Methodology/Research Approach
  - 10.1.1.1 Research Programs/Design
  - 10.1.1.2 Market Size Estimation
  - 10.1.1.3 Market Breakdown and Data Triangulation
- 10.1.2 Data Source
  - 10.1.2.1 Secondary Sources
  - 10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

List of Tables

Table 1. Anti-aging Drugs Market Trends
Table 2. Anti-aging Drugs Market Drivers & Opportunity
Table 3. Anti-aging Drugs Market Challenges
Table 4. Anti-aging Drugs Market Restraints
Table 5. Global Anti-aging Drugs Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Anti-aging Drugs Revenue Market Share by Company (2020-2025)
Table 7. Global Anti-aging Drugs Sales Volume by Company (2020-2025) & (K Units)
Table 8. Global Anti-aging Drugs Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Anti-aging Drugs Price by Company (2020-2025) & (US$/Unit)
Table 10. Key Manufacturers Anti-aging Drugs Manufacturing Base and Headquarters
Table 11. Key Manufacturers Anti-aging Drugs Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Anti-aging Drugs
Table 13. Global Anti-aging Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-aging Drugs as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-aging Drugs Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Anti-aging Drugs Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Anti-aging Drugs Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Anti-aging Drugs Sales Market Share in Value by Type (2020-2025)
Table 20. Global Anti-aging Drugs Sales Market Share in Value by Type (2026-2031)
Table 21. Global Anti-aging Drugs Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
Table 22. Global Anti-aging Drugs Sales Volume by Type (2020-2025) & (K Units)
Table 23. Global Anti-aging Drugs Sales Volume by Type (2026-2031) & (K Units)
Table 24. Global Anti-aging Drugs Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Anti-aging Drugs Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Anti-aging Drugs Price by Type (2020-2025) & (US$/Unit)
Table 27. Global Anti-aging Drugs Price by Type (2026-2031) & (US$/Unit)
Table 28. Global Anti-aging Drugs Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Anti-aging Drugs Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Anti-aging Drugs Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Anti-aging Drugs Sales Market Share in Value by Application (2020-2025)
Table 32. Global Anti-aging Drugs Sales Market Share in Value by Application (2026-2031)
Table 33. Global Anti-aging Drugs Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
Table 34. Global Anti-aging Drugs Sales Volume by Application (2020-2025) & (K Units)
Table 35. Global Anti-aging Drugs Sales Volume by Application (2026-2031) & (K Units)
Table 36. Global Anti-aging Drugs Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Anti-aging Drugs Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Anti-aging Drugs Price by Application (2020-2025) & (US$/Unit)
Table 39. Global Anti-aging Drugs Price by Application (2026-2031) & (US$/Unit)
Table 40. Global Anti-aging Drugs Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Anti-aging Drugs Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Anti-aging Drugs Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Anti-aging Drugs Sales Value by Region (2020-2025) & (%)
Table 44. Global Anti-aging Drugs Sales Value by Region (2026-2031) & (%)
Table 45. Global Anti-aging Drugs Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
Table 46. Global Anti-aging Drugs Sales Volume by Region (2020-2025) & (K Units)
Table 47. Global Anti-aging Drugs Sales Volume by Region (2026-2031) & (K Units)
Table 48. Global Anti-aging Drugs Sales Volume by Region (2020-2025) & (%)
Table 49. Global Anti-aging Drugs Sales Volume by Region (2026-2031) & (%)
Table 50. Global Anti-aging Drugs Average Price by Region (2020-2025) & (US$/Unit)
Table 51. Global Anti-aging Drugs Average Price by Region (2026-2031) & (US$/Unit)
Table 52. Key Countries/Regions Anti-aging Drugs Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Anti-aging Drugs Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Anti-aging Drugs Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Anti-aging Drugs Sales Volume, (2020-2025) & (K Units)
Table 56. Key Countries/Regions Anti-aging Drugs Sales Volume, (2026-2031) & (K Units)
Table 57. AbbVie Company Information
Table 58. AbbVie Introduction and Business Overview
Table 59. AbbVie Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 60. AbbVie Anti-aging Drugs Product Offerings
Table 61. AbbVie Recent Development
Table 62. Galderma Company Information
Table 63. Galderma Introduction and Business Overview
Table 64. Galderma Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 65. Galderma Anti-aging Drugs Product Offerings
Table 66. Galderma Recent Development
Table 67. LG Life Sciences Company Information
Table 68. LG Life Sciences Introduction and Business Overview
Table 69. LG Life Sciences Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 70. LG Life Sciences Anti-aging Drugs Product Offerings
Table 71. LG Life Sciences Recent Development
Table 72. Merz Company Information
Table 73. Merz Introduction and Business Overview
Table 74. Merz Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Merz Anti-aging Drugs Product Offerings
Table 76. Merz Recent Development
Table 77. Medytox Company Information
Table 78. Medytox Introduction and Business Overview
Table 79. Medytox Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Medytox Anti-aging Drugs Product Offerings
Table 81. Medytox Recent Development
Table 82. Hugel Company Information
Table 83. Hugel Introduction and Business Overview
Table 84. Hugel Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Hugel Anti-aging Drugs Product Offerings
Table 86. Hugel Recent Development
Table 87. Croma-Pharma Company Information
Table 88. Croma-Pharma Introduction and Business Overview
Table 89. Croma-Pharma Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Croma-Pharma Anti-aging Drugs Product Offerings
Table 91. Croma-Pharma Recent Development
Table 92. Beijing IMEIK Company Information
Table 93. Beijing IMEIK Introduction and Business Overview
Table 94. Beijing IMEIK Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Beijing IMEIK Anti-aging Drugs Product Offerings
Table 96. Beijing IMEIK Recent Development
Table 97. Bloomage Bio Company Information
Table 98. Bloomage Bio Introduction and Business Overview
Table 99. Bloomage Bio Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Bloomage Bio Anti-aging Drugs Product Offerings
Table 101. Bloomage Bio Recent Development
Table 102. Elravie (Humedix) Company Information
Table 103. Elravie (Humedix) Introduction and Business Overview
Table 104. Elravie (Humedix) Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. Elravie (Humedix) Anti-aging Drugs Product Offerings
Table 106. Elravie (Humedix) Recent Development
Table 107. Cleviel (Pharma Research Products) Company Information
Table 108. Cleviel (Pharma Research Products) Introduction and Business Overview
Table 109. Cleviel (Pharma Research Products) Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Cleviel (Pharma Research Products) Anti-aging Drugs Product Offerings
Table 111. Cleviel (Pharma Research Products) Recent Development
Table 112. Haohai Biological Company Information
Table 113. Haohai Biological Introduction and Business Overview
Table 114. Haohai Biological Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. Haohai Biological Anti-aging Drugs Product Offerings
Table 116. Haohai Biological Recent Development
Table 117. Teoxane Company Information
Table 118. Teoxane Introduction and Business Overview
Table 119. Teoxane Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. Teoxane Anti-aging Drugs Product Offerings
Table 121. Teoxane Recent Development
Table 122. Sinclair Company Information
Table 123. Sinclair Introduction and Business Overview
Table 124. Sinclair Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 125. Sinclair Anti-aging Drugs Product Offerings
Table 126. Sinclair Recent Development
Table 127. Suneva Medical Company Information
Table 128. Suneva Medical Introduction and Business Overview
Table 129. Suneva Medical Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 130. Suneva Medical Anti-aging Drugs Product Offerings
Table 131. Suneva Medical Recent Development
Table 132. CG Bio Company Information
Table 133. CG Bio Introduction and Business Overview
Table 134. CG Bio Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 135. CG Bio Anti-aging Drugs Product Offerings
Table 136. CG Bio Recent Development
Table 137. SciVision Biotech Company Information
Table 138. SciVision Biotech Introduction and Business Overview
Table 139. SciVision Biotech Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 140. SciVision Biotech Anti-aging Drugs Product Offerings
Table 141. SciVision Biotech Recent Development
Table 142. Prollenium Company Information
Table 143. Prollenium Introduction and Business Overview
Table 144. Prollenium Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 145. Prollenium Anti-aging Drugs Product Offerings
Table 146. Prollenium Recent Development
Table 147. Bohus BioTech Company Information
Table 148. Bohus BioTech Introduction and Business Overview
Table 149. Bohus BioTech Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 150. Bohus BioTech Anti-aging Drugs Product Offerings
Table 151. Bohus BioTech Recent Development
Table 152. Caregen Company Information
Table 153. Caregen Introduction and Business Overview
Table 154. Caregen Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 155. Caregen Anti-aging Drugs Product Offerings
Table 156. Caregen Recent Development
Table 157. Ipsen Company Information
Table 158. Ipsen Introduction and Business Overview
Table 159. Ipsen Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 160. Ipsen Anti-aging Drugs Product Offerings
Table 161. Ipsen Recent Development
Table 162. LIBP Company Information
Table 163. LIBP Introduction and Business Overview
Table 164. LIBP Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 165. LIBP Anti-aging Drugs Product Offerings
Table 166. LIBP Recent Development
Table 167. US World Meds Company Information
Table 168. US World Meds Introduction and Business Overview
Table 169. US World Meds Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 170. US World Meds Anti-aging Drugs Product Offerings
Table 171. US World Meds Recent Development
Table 172. Daewoong Company Information
Table 173. Daewoong Introduction and Business Overview
Table 174. Daewoong Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 175. Daewoong Anti-aging Drugs Product Offerings
Table 176. Daewoong Recent Development
Table 177. JETEMA Company Information
Table 178. JETEMA Introduction and Business Overview
Table 179. JETEMA Anti-aging Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 180. JETEMA Anti-aging Drugs Product Offerings
Table 181. JETEMA Recent Development
Table 182. Key Raw Materials Lists
Table 183. Raw Materials Key Suppliers Lists
Table 184. Anti-aging Drugs Downstream Customers
Table 185. Anti-aging Drugs Distributors List
Table 186. Research Programs/Design for This Report
Table 187. Key Data Information from Secondary Sources
Table 188. Key Data Information from Primary Sources

List of Figures

Figure 1. Anti-aging Drugs Product Picture
Figure 2. Global Anti-aging Drugs Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Anti-aging Drugs Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Anti-aging Drugs Sales Volume (2020-2031) & (K Units)
Figure 5. Global Anti-aging Drugs Sales Price (2020-2031) & (US$/Unit)
Figure 6. Anti-aging Drugs Report Years Considered
Figure 7. Global Anti-aging Drugs Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Anti-aging Drugs Players Sales Volume Ranking (2024) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-aging Drugs Revenue in 2024
Figure 10. Anti-aging Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Dermal Fillers Picture
Figure 12. Botulinum Toxin Picture
Figure 13. Others Picture
Figure 14. Global Anti-aging Drugs Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 15. Global Anti-aging Drugs Sales Value Market Share by Type, 2024 & 2031
Figure 16. Global Anti-aging Drugs Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
Figure 17. Global Anti-aging Drugs Sales Volume Market Share by Type, 2024 & 2031
Figure 18. Global Anti-aging Drugs Price by Type (2020-2031) & (US$/Unit)
Figure 19. Product Picture of Hospital
Figure 20. Product Picture of Beauty Parlor
Figure 21. Product Picture of Others
Figure 22. Global Anti-aging Drugs Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 23. Global Anti-aging Drugs Sales Value Market Share by Application, 2024 & 2031
Figure 24. Global Anti-aging Drugs Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
Figure 25. Global Anti-aging Drugs Sales Volume Market Share by Application, 2024 & 2031
Figure 26. Global Anti-aging Drugs Price by Application (2020-2031) & (US$/Unit)
Figure 27. North America Anti-aging Drugs Sales Value (2020-2031) & (US$ Million)
Figure 28. North America Anti-aging Drugs Sales Value by Country (%), 2024 VS 2031
Figure 29. Europe Anti-aging Drugs Sales Value, (2020-2031) & (US$ Million)
Figure 30. Europe Anti-aging Drugs Sales Value by Country (%), 2024 VS 2031
Figure 31. Asia Pacific Anti-aging Drugs Sales Value, (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Anti-aging Drugs Sales Value by Region (%), 2024 VS 2031
Figure 33. South America Anti-aging Drugs Sales Value, (2020-2031) & (US$ Million)
Figure 34. South America Anti-aging Drugs Sales Value by Country (%), 2024 VS 2031
Figure 35. Middle East & Africa Anti-aging Drugs Sales Value, (2020-2031) & (US$ Million)
Figure 36. Middle East & Africa Anti-aging Drugs Sales Value by Country (%), 2024 VS 2031
Figure 37. Key Countries/Regions Anti-aging Drugs Sales Value (%), (2020-2031)
Figure 38. Key Countries/Regions Anti-aging Drugs Sales Volume (%), (2020-2031)
Figure 39. United States Anti-aging Drugs Sales Value, (2020-2031) & (US$ Million)
Figure 40. United States Anti-aging Drugs Sales Value by Type (%), 2024 VS 2031
Figure 41. United States Anti-aging Drugs Sales Value by Application (%), 2024 VS 2031
Figure 42. Europe Anti-aging Drugs Sales Value, (2020-2031) & (US$ Million)
Figure 43. Europe Anti-aging Drugs Sales Value by Type (%), 2024 VS 2031
Figure 44. Europe Anti-aging Drugs Sales Value by Application (%), 2024 VS 2031
Figure 45. China Anti-aging Drugs Sales Value, (2020-2031) & (US$ Million)
Figure 46. China Anti-aging Drugs Sales Value by Type (%), 2024 VS 2031
Figure 47. China Anti-aging Drugs Sales Value by Application (%), 2024 VS 2031
Figure 48. Japan Anti-aging Drugs Sales Value, (2020-2031) & (US$ Million)
Figure 49. Japan Anti-aging Drugs Sales Value by Type (%), 2024 VS 2031
Figure 50. Japan Anti-aging Drugs Sales Value by Application (%), 2024 VS 2031
Figure 51. South Korea Anti-aging Drugs Sales Value, (2020-2031) & (US$ Million)
Figure 52. South Korea Anti-aging Drugs Sales Value by Type (%), 2024 VS 2031
Figure 53. South Korea Anti-aging Drugs Sales Value by Application (%), 2024 VS 2031
Figure 54. Southeast Asia Anti-aging Drugs Sales Value, (2020-2031) & (US$ Million)
Figure 55. Southeast Asia Anti-aging Drugs Sales Value by Type (%), 2024 VS 2031
Figure 56. Southeast Asia Anti-aging Drugs Sales Value by Application (%), 2024 VS 2031
Figure 57. India Anti-aging Drugs Sales Value, (2020-2031) & (US$ Million)
Figure 58. India Anti-aging Drugs Sales Value by Type (%), 2024 VS 2031
Figure 59. India Anti-aging Drugs Sales Value by Application (%), 2024 VS 2031
Figure 60. Anti-aging Drugs Industrial Chain
Figure 61. Anti-aging Drugs Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

Anti-aging Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Description

Table of Contents

List of Tables

Table of Contents

1 Market Overview

2 Competitive Analysis by Company

3 Segmentation by Type

4 Segmentation by Application

5 Segmentation by Region

6 Segmentation by Key Countries/Regions

7 Company Profiles

8 Industry Chain Analysis

9 Research Findings and Conclusion

10 Appendix

List of Tables

List of Figures